We believe cancer kills too many people.
Our mission is to change that.
Today’s cancer diagnostic methods are not good enough. They catch cancer too late.
Researchers do not have the tools they need to find the signals for early disease detection and diagnosis. Extracellular vesicles (EVs) drive inter-cellular communication within our bodies and hold the key to early cancer detection. We are putting our breakthrough technology in the hands of researchers to speed up the fight against cancer.
EXOKERYX is leveraging semiconductor technology to power best-in-class tools for isolation, detection, and analysis of extracellular vesicles. Decoding extracellular vesicle biomarkers allows us to define unique fingerprints for earlier cancer detection.
Cancer Fingerprint™, powered by our chip-based sensor, delivers the sensitivity and affordability necessary to make it possible for everyone to be tested yearly for cancer.
Together, we can drive discovery, detect cancer earlier, and save lives.
Meet The Founders
President and CTO
EXOKĒRYX exists at the intersection of solid-state electronics and biomarker discovery .
We've created a culture where risk taking is encouraged and rewarded. Our interdisciplinary team of physicists, biologists, and engineers are empowered to try creative approaches based on where the data is taking us.
We are results-driven and collaborative because we know the best ideas come from open, constructive dialog.
Bryan Rice, our President and CTO, captures our culture best with: “At EXOKĒRYX, failure is okay, as long as you can learn from it quickly. That’s what drives transformation and innovation.”
At EXOKĒRYX, we try, learn, fail forward, and iterate.